Cost-Effectiveness of Typical and Atypical Drugs Combination for Outpatients at RSJD Surakarta
Year: 2025
Type: article
Study design: Observational Study
Abstract: Introduction: Schizophrenia treatment requires an analysis of more effective drug combinations, resulting in shorter treatment durations and hospital stays, ultimately reducing overall treatment costs. Objective: To analyze the cost-effectiveness of two classes of antipsychotic drugs in the treatment of schizophrenia inpatients at Dr. Arif Zainuddin Regional Mental Hospital, Surakarta, in 2022. Methods: This study is a non-experimental analytical study using purposive sampling. The inclusion criteria were schizophrenic patients in the inpatient unit of the Dr. Arif Zainuddin Regional Mental Hospital in Surakarta. The data used for this study were medical records, drug costs, and the National Assessment and Assessment System (PAANS) obtained from the Administration Department of the Dr. Arif Zainuddin Regional Mental Hospital. This study employed cost-effectiveness analysis techniques using the drug effectiveness formula, ACER, and ICER, which were then analyzed descriptively. Results: The results of this study concluded that the cost-effectiveness of treating schizophrenic patients with a combination of typical and atypical antipsychotic drugs in the inpatient unit of the Dr. Arif Zainuddin Regional Mental Hospital in Surakarta was significant. The combination of atypical typical antipsychotics, a combination of olanzapine and haloperidol with an ACER value of Rp. 333,620.5 and an ICER value of Rp. 60,005.8/day of treatment with a treatment duration of around 9 to 10 days.
Institution: STIKES Mamba'ul 'Ulum Surakarta
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7204647701